Amring Pharmaceuticals recalls

Amring Pharmaceuticals appears in 1 official U.S. recall notice indexed by RecallRadar, most recently on 2023-06-21.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc
  FDA Drug · Class III · 2023-06-21 · Amring Pharmaceuticals